STRONGEST HOPE YET

The report of the Phase 1 trial suggests the vaccine developed by researchers at Oxford University may be the biggest boost yet in the fight against the Covid-19 pandemic

WHAT THIS MEANS

The fact the vaccine also triggered a T cell response is an encouraging sign. A T cell response means the vaccine was able to stimulate the part of the immunity that ‘learns’.

STILL UNKNOWN

The researchers said more study is needed to check if this vaccine is enough to prevent an infection (it has been shown to lead to a response that can fight the infection)

Phase 2 and 3 trials are now underway to test how the vaccine behaves among people of different age groups and ethnicities as well those who might have some underlying health conditions.